Mohsen Chiani
Impact in
- Pharmaceutical Science top 2%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 7
- Bacterial biofilms and quorum sensing 4
- Biomaterials 17
- Nanoparticle-Based Drug Delivery 15
- Co-authors
- Mohammad Reza Mehrabi (21 shared papers)Azim Akbarzadeh (23 shared papers)Dariush Norouzian (11 shared papers)Ali Akbar Farhangi (14 shared papers)M. Soltani (4 shared papers)Iman Akbarzadeh (3 shared papers)Mohammad Souri (3 shared papers)Mohammad Kiani Shahvandi (2 shared papers)
- Journals
- International Immunopharmacology (2 papers)Nanomaterials (2 papers)Artificial Cells Nanomedicine and Biotechnology (2 papers)Scientific Reports (1 paper)International Journal of Pharmaceutics (1 paper)
- Partner nations
- IranUnited StatesCanada
In The Last Decade
Mohsen Chiani
63 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 105
- Pharmaceutical Science 186
- Biomaterials 340
- Molecular Medicine 90
- Rehabilitation 45
- Microbiology 42
Countries citing papers authored by Mohsen Chiani
This map shows the geographic impact of Mohsen Chiani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohsen Chiani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohsen Chiani more than expected).
Fields of papers citing papers by Mohsen Chiani
This network shows the impact of papers produced by Mohsen Chiani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohsen Chiani. The network helps show where Mohsen Chiani may publish in the future.
Co-authors
The 25 scholars most cited alongside Mohsen Chiani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 122 | |
| 2 | 2020 | 77 | |
| 3 | 2008 | 70 | |
| 4 | 2014 | 66 | |
| 5 | 2022 | 56 | |
| 6 | 2013 | 56 | |
| 7 | 2020 | 50 | |
| 8 | Contributions of MYOC and CYP1B1 mutations to JOAG. | 2008 | 46 |
| 9 | 2023 | 44 | |
| 10 | 2017 | 38 | |
| 11 | 2022 | 37 | |
| 12 | 2011 | 35 | |
| 13 | 2018 | 32 | |
| 14 | 2016 | 30 | |
| 15 | 2010 | 30 | |
| 16 | 2017 | 28 | |
| 17 | 2022 | 27 | |
| 18 | 2010 | 25 | |
| 19 | 2014 | 24 | |
| 20 | 2020 | 22 |
About Mohsen Chiani
Mohsen Chiani is a scholar working on Molecular Biology, Biomaterials, Pharmaceutical Science, Oncology and Microbiology, having authored 69 papers that have together received 1.3k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (15 papers), Advancements in Transdermal Drug Delivery (14 papers), RNA Interference and Gene Delivery (7 papers), Antimicrobial Peptides and Activities (6 papers), Bacterial biofilms and quorum sensing (4 papers), Curcumin's Biomedical Applications (4 papers), Cancer Treatment and Pharmacology (3 papers) and Nanoparticles: synthesis and applications (3 papers). The work is most often cited by research in Pharmaceutical Science (186 citations), Biomaterials (340 citations), Molecular Medicine (90 citations), Rehabilitation (45 citations) and Microbiology (42 citations). Mohsen Chiani has collaborated with scholars based in Iran, United States and Canada. Frequent co-authors include Mohammad Reza Mehrabi, Azim Akbarzadeh, Dariush Norouzian, Ali Akbar Farhangi, M. Soltani, Iman Akbarzadeh, Mohammad Souri, Mohammad Kiani Shahvandi, Farshad Moradi Kashkooli and Zahra Saffari. Their work appears in journals such as International Immunopharmacology, Nanomaterials, Artificial Cells Nanomedicine and Biotechnology, Scientific Reports and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.